Here are some of the top life sciences news stories and tweets from the week (March 31 – April 4, 2014). Pumping up: Intarcia’s $200M financing for new exenatide route makes it the highest-valued privately held biotech http://t.co/TdkwCGp0o1 — BioWorld Today (@BioWorld) April 2, 2014 Janssen submits NDA to US FDA for FDC darunavir + […]
written on 04.04.2014
Top Life Sciences News Stories Vol. 41
